JF

John Friend

Kazia Therapeutics Limited | Chief Executive Officer, Managing Director, Interim chairman
Dr Friend is an physician executive with a more than 25 year career history and background in establishing and leading critical business units in small to mid-sized biopharmaceutical companies. Prior to joining Kazia, he was Chief Medical Officer at Cellectar Biosciences, Inc (NASDAQ: CLRB), a clinical-stage, oncology-focused biotech company based in Florham Park, NJ. Prior to his time at Cellectar, he held executive roles with responsibility for research & development, regulatory affairs, medical affairs, pharmacovigilance and risk management at various pharmaceutical companies including Helsinn Therapeutics, Akros Pharma, Actavis, Alpharma, Hospira and Abbott Laboratories.

Company and Roles

Company
Title
Tenure
Since
KZA
Kazia Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
  • Interim chairman
1yrs, 7mthMay 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
KZA
Kazia Therapeutics Limited
01/08/23N/AN/A4,800,000N/A